TABLE 1.
Baseline Characteristics (N = 150)
| Characteristic | Results |
|---|---|
| Age, mean (SD), y | 69.5 (9.7) |
|
| |
| Sex, No. (%) | |
| Male | 142 (94.7) |
| Female | 8 (5.3) |
|
| |
| Race, White, No. (%) | 134 (89.3) |
|
| |
| Medications, No. (%) | |
| Insulin | 150 (100) |
| Sodium-glucose cotransporter 2-inhibitors | 28 (18.7) |
| Glucagon-like peptide-1 inhibitors | 17 (11.3) |
| Biguanides | 70 (46.7) |
| Dipeptidyl peptidase-4 inhibitors | 11 (7.3) |
| Thiazolidinediones | 6 (4.0) |
| Sulfonylureas | 4 (2.7) |